Novo valuation surpasses Tesla on experimental obesity drug data
Go back to Novo valuation surpasses Tesla on experimental obesity drug data| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1182.44 -24.83 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1207.27 | 52 Week High | $88.16 | |||
| Open | $1194.01 | 52 Week Low | $67.88 | |||
| Day High | $1199.00 | P/E | 273.71 | |||
| Day Low | $1171.20 | EPS | $4.32 | |||
| Volume | 1,223,938 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.20 -0.52 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.72 | 52 Week High | $59.00 | |||
| Open | $46.90 | 52 Week Low | $32.80 | |||
| Day High | $47.05 | P/E | N/A | |||
| Day Low | $45.93 | EPS | $0.00 | |||
| Volume | 6,534,629 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 33.15 +0.21 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.94 | 52 Week High | $5.17 | |||
| Open | $32.56 | 52 Week Low | $0.94 | |||
| Day High | $33.18 | P/E | N/A | |||
| Day Low | $32.33 | EPS | $0.00 | |||
| Volume | 691,023 | |||||
